Intensive Studies for Recertification: Ambulatory Care (Cert #L199019)

ACPE Numbers:
0204-9999-18-227-H01-P
0204-9999-18-296-H01-P
0204-9999-18-274-H04-P
0204-9999-18-322-H01-P

Release Date: 02/06/2019
Expiration Date: 08/06/2019
Activity Type: Application-based
CE Credits: 6 hours
Activity Fee: $100 (ASHP member); $150 (non-member) 

Accreditation for Pharmacists

The American Society of Health-System Pharmacists and the American Pharmacists Association are accredited by the Accreditation Council for Pharmacy Education as a providers of continuing pharmacy education.

These activities were recorded during a live educational event on December 3-5, 2018 at the Midyear Clinical Meeting in Anaheim, California. Learners who claimed credit for the live activities should not claim credit for these home study activities. 

Target Audience

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • Antidiabetic drug therapy
  • Pharmacogenomics

Activity Overview

The Intensive Study Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in ambulatory care. 

The Ambulatory Care Intensive Study  Recertification Package consists of 4 activities (see table below) recorded during a live educational event on December 3-5, 2018 at the Midyear Clinical Meeting in Anaheim, California  and provides up to 6 hours of continuing pharmacy education and/or recertification credit.   

These activities are part of the ASHP professional development program for BCACP recertification approved by the BPS. For pharmacists who maintain more than one certification, all of the activities are approved for multiple specialties (see table below). 

Recertification Credit*

Board certified pharmacists are eligible to receive up to 6 hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Participants who pass the assessments between February 6, 2019 – August 6, 2019, will be eligible for recertification credit for 2019.

Learning Module

ACPE Number

Credit Hours

Specialty

*Assessment Pass Point

Expanding the Roles of Clinical Pharmacogenomics and Its Implementation

0204-9999-18-227-H01-P

1.5

BCACP, BCCCP, BCGP, BCPPS, BCPS

71%

A Look at Psychiatric Pharmacogenomics in Practice

0204-9999-18-296-H01-P

1.5

BCACP, BCGP

64%

Using Population Health Initiatives to Expand Pharmacist Services

0204-9999-18-274-H04-P

1

BCACP, BCGP

66%

Examining the Influence of Cardiovascular Outcome Trials: Is It the Heart of Diabetes?

0204-9999-18-322-H01-P

2

BCACP, BCPS

76%

Learning Objectives


Expanding the Roles of Clinical Pharmacogenomics and Its Implementation
0204-9999-18-227-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Recommend the key steps in the implementation of pharmacogenetics testing in clinical practice.
  • Evaluate strategies to initiate pharmacogenetic testing at your organization.
  • Given a case study, evaluate key elements of a pharmacogenomics testing product.
  • Given a case study, recommend appropriate pharmacogenomics resources based on specific needs in the implementation process.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP), Board Certified Critical Care Pharmacist (BCCCP), Board Certified Geriatric Pharmacist (BCGP), Board Certified Pediatric Pharmacy Specialist (BCPPS), and Board Certified Pharmacotherapy Specialist (BCPS) recertification credit. 

A Look at Psychiatric Pharmacogenomics in Practice
0204-9999-18-296-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Given the results of pharmacogenomic testing, provide patient-specific recommendations for antidepressant and antipsychotic use.
  • Interpret pharmacogenomic results and recommend appropriate therapy for geriatric patients with depression.
  • Compare Clinical Pharmacogenomics Implementation Consortium (CPIC) guideline recommendations with interpretation results from a commercial laboratory.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit. 

Using Population Health Initiatives to Expand Pharmacist Services
0204-9999-18-274-H04-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Analyze priority areas of population health and related metrics for pharmacist impact.
  • Evaluate implementation strategies of pharmacist resources to improve population health.
  • Evaluate population health initiatives supporting pharmacist expansion.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit. 

Examining the Influence of Cardiovascular Outcome Trials: Is It the Heart of Diabetes?
0204-9999-18-322-H01-P

  • Evaluate the potential benefits of antidiabetic therapy beyond A1C lowering effects.
  • Given a case study, analyze the results from antidiabetic therapy cardiovascular outcome clinical trials (CVOT).
  • Given a case study, design an individualized, evidence-based pharmacotherapeutic plan for a patient with type 2 diabetes.
  • Given a scenario, recommend strategies for identifying and integrating into practice the results of new CVOT literature involving antidiabetic drug therapy.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Pharmacotherapy Specialist (BCPS) recertification credit. 

Faculty

Gillian C. Bell, Pharm.D.
Interim Director, Personalized Medicine
Mission Health
Asheville, North Carolina 

Henry Dunnenberger, Pharm.D., BCPS
Director, Pharmacogenomics
NorthShore University HealthSystem
Evanston, Illinois 

Vicki L. Ellingrod, Pharm.D., FCCP
Associate Dean for Research and Graduate Education
University of Michigan College of Pharmacy
Ann Arbor, Michigan 

Kelly Epplen, Pharm.D., B.S.Pharm., BCACP, FASHP
Associate Professor of Clinical Pharmacy Practice
The James L. Winkle College of Pharmacy
University of Cincinnati
Cincinnati, Ohio 

Melody Hartzler, Pharm.D., AE-C, BCACP, BC-ADM
Clinical Pharmacist
Chronic Care Management Coordinator
Western Medicine, Inc.
Fairborn, Ohio 

Kristi W. Kelley, Pharm.D., BCACP, BC-ADM, BCPS, CDE
Clinical Professor, Pharmacy Practice
Clinical Pharmacist
Auburn University Harrison School of Pharmacy and Continuity of Care Internal
Clinical Pharmacist
Baptist Health, Inc.
Birmingham, Alabama 

Matthew Kostoff, Pharm.D., BCACP, BCPS
Clinical Lead Pharmacist, Population Health
Summa Health
Akron, Ohio 

Kristen Ward, Pharm.D.
Clinical Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan 

Content Matter Experts

Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP
Professor, Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Louisville, Kentucky 

Dana Carroll, Pharm.D., BCGP, BCPS, CDE
Associate Clinical Professor
Auburn University Harrison School of Pharmacy
Adjunct Associate Professor
University of Alabama Family Medicine
Tuscaloosa, Alabama 

Angela Colella, Pharm.D., BCPS
Drug Use Policy Coordinator
Advocate Aurora Health Care
Cincinnati, Ohio 

Kelly Epplen, Pharm.D., B.S.Pharm., BCACP, FASHP
Associate Professor of Clinical Pharmacy Practice
The James L. Winkle College of Pharmacy
University of Cincinnati
Cincinnati, Ohio 

Stuart T. Haines, Pharm.D., BCACP, BC-ADM, BCPS
Professor, Department of Pharmacy Practice
Director, Pharmacy Professional Development
University of Mississippi College of Pharmacy
Jackson, Mississippi 

Peter N. Johnson, Pharm.D., BCPPS, BCPS, FCCM, FPPAG
Associate Professor of Pharmacy Practice
University of Oklahoma College of Pharmacy
Adjunct Associate
University of Oklahoma - College of Medicine
Oklahoma City, Oklahoma
Roberts 

Maria Shin, Pharm.D., BCGP, BCPS
Assistant Professor
Sullivan University College of Pharmacy
Louisville, Kentucky 

Douglas Slain, Pharm.D., BCPS-AQ ID, FASHP, FCCP
Associate Professor and Infectious Diseases Clinical Specialist
West Virginia University School of Pharmacy
Morgantown, West Virginia 

Paul M. Szumita, Pharm.D., BCCCP, BCPS, FASHP, FCCM
Clinical Pharmacy Practice Manager
Brigham and Women's Hospital
Foxboro, Massachusetts 

Reviewers

Holly L. Byrnes, Pharm D., BCPS
Susan R. Dombrowski, M.S., R.Ph.
Kristi Hofer, Pharm.D.
Robert Tremmel, Pharm.D., R.Ph. 

Field Testers

Ramadas Balasubramanian, BCACP, BCGP
Jennifer Banks, Pharm.D, BCACP, BCGP, BCPS, BC-ADM, CDE
Jonathan Bartlett, Pharm.D., BCACP
Shaneka Baylor, Pharm.D., BCACP, BCGP
Monica Bogenschutz, Pharm.D, BCPPS, BCPS
Agnes Cha, Pharm.D., BCACP, AAHIVP
Heather Dedman, B.Sc., BSP, BCPPS
Shimaa Elsayed Ahmed, B.S. Pharm., BCACP, BCGP
Elizabeth Claire Elson, Pharm.D., BCPPS
Nicholas Farina, Pharm.D., BCCCP
Brian Ferullo, Pharm.D., BCGP
Jessica Gentile, Pharm.D., BCGP, BCPS
Bonnie Hammond, R.Ph., BCGP
Amy Holmes, Pharm.D., BCPPS
Amy Inderlied, Pharm.D., BCACP
Casey Kamps, Pharm.D., BCACP
Jessica Klingaman, BCGP
Suwen Lim, M.ClinPharm, BCACP, BCGP, BCOP, BCPS
Jennifer Lis, Pharm.D., BCACP
Laura McAuliffe, Pharm.D., BCACP
Jessica McDaniel, Pharm.D., BCACP
Lindsey McIver, Pharm.D., BCACP
Krista Millette-Rocan, Pharm.D., B.S.Pharm.,  BCGP, CDE
Taryn Mondiello, Pharm.D., BCACP
Rui Yi Neo, BCPS
Frances Ngok, Pharm.D., BCACP, CDE
Roger Pritchard, Pharm.D., BCACP
Gehad Ramadan, BCPS
Amira Shahin, BCPS
Melanie Smith, Pharm.D., BCACP, DPLA
Mahmoud Tammam, BCPS
Colleen Teevan, PharmD, BCCCP, BCPS
uliana Zschoche, Pharm.D., BCPS

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Henry Dunnenberger
    • Admera Health - Consultant, Honorarium
    • Veritas Genetics - Consultant
  • Melody Hartzler
    • Janssen – Speakers Bureau
    • Valeritas – Speakers Bureau
  • All other presenters, program chairs, planners, reviewers, staff, and others with an opportunity to control CE content, have nothing to disclose. 

Methods and CE Requirements

Activities consist of audio/ video/PDF files, an attestation statement, and activity evaluation. Learners must review all content and complete the attestation statement and course evaluation to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

System Technical Requirements

Learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites. 

View the minimum technical and system requirements for learning activities. 

Development

These activities were developed in partnership between ASHP and the American Pharmacists Association (APhA).